Description: LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA) Research Institute, and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. This report documents a high-level analysis of the claims that have been reported.

Description: The report discusses using behavioral science in redesigning life insurance underwriting questionnaires to improve disclosure rates. It includes an experimental study, industry survey insights, and discussions on application forms, behavioral science application, and organizational engagement with behavioral science in the insurance industry.

Description: The Mortality Improvement Life Working Group released a recommendation for a set of improvement factors that vary by gender and attained age to be used in conjunction with the 2008 Valuation Basic table or the 2015 Valuation Basic table for AG-38 purposes.

Description: The SOA’s Committee on Life Insurance Company Expenses (CLICE) has submitted its recommendation for the 2026 Generally Recognized Expense Table (GRET) for use with individual life insurance sales illustrations. This recommendation was adopted by LATF on October 2, 2025.

Description: Recommendation for a set of improvement factors to be used in conjunction with the 2008 Valuation Basic table or the 2015 Valuation Basic table

Description: One of the evolving datasets with the COVID-19 Research Database is the Datavant population mortality information. This report notes the features of the database, discuss their potential use and limitations, examines data reliability and reviews it potential use as an additional data set and input to mortality improvement models.

Description: Deaths due to non-medical causes such as drug overdoses, alcohol-related deaths, homicides, suicides and accidents are the leading cause of death for those under the age of 50 in the U.S. and is the fourth leading cause of death (after cardiovascular, cancer and COVID-19) for all ages combined in 2021. Take a deep dive with us into the mortality trends for non-medical causes of death and the impact these deaths have on different types of life insurance, including simplified issued, fully underwritten and group.

Description: Much has been published about the increased financial statement volatility under U.S. GAAP Long Duration Targeted Improvements (LDTI). Discover more about tools and techniques that actuaries and other financial reporting professionals can use to reduce volatility risk and understand the relationships between certain risks and volatility. By attending the session, you will learn to identify sources of financial statement volatility under LDTI and methods to manage or reduce the volatility.

Description: In this wide-ranging session, expect updates on the work of the Individual Life Experience Committee and delve into some interesting recent research. You'll gain an update on recent findings from the Individual Life Experience Committee regarding individual life mortality experience.

Description: Mortality improvement assumptions have typically been focused on all-cause mortality improvement. However, as evidenced in recent years, the cause of death has a large impact on mortality improvement. Join our panel of experts as they discuss mortality improvement through the lens of different causes of death. This discussion will include a review of the historical cause specific mortality improvement trends seen in the U.S. population and how this relates to the insured population. The panelists will then discuss how to use these trends to inform future mortality improvement assumptions. Key learning objectives include: - Identifying the trends in mortality improvement for select causes of death - Understanding how to adapt these for an insured population - Applying these learnings to mortality improvement assumptions